BRISTOL MYERS SQUIBB CO
BMY- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000014272
Other share classesCELG.RI
Insider trades, last 90 days
0 buys · 2 sells
- Sold $437.25K
- Open-market purchases (P) and sales (S), counted by Form 4 filing.
13F holders, Q2 2026
2,529
- −15 vs. Q1 2026
- Total value $104.55B
Superinvestors holding BMY
0
- None of the superinvestors held BMY at the end of Q2 2026.
Price chart
Latest insider trades
View all: Latest insider tradesOpen-market purchases and sales by BMY insiders, newest first.
| Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Sep 10, 20264:37 PM ET | Sep 9, 2026 | Massacesi CristianEVP,Chief Med Offr,Head of Dev | SSaleCommon Stock, $0.10 par value | −6.25K | $64.57 | −$403.5K | 18.75K | −25.0% | SEC |
| Aug 26, 20264:17 PM ET | Aug 25, 2026 | Holzer Phil MSVP and Controller | SSaleCommon Stock, $0.10 par value | −500 | $67.50 | −$33.75K | 16.86K | −2.9% | SEC |
| Apr 2, 2026 | Apr 1, 2026 | Elkins David VEVP, Chief Financial Officer | SSaleCommon Stock, $0.10 par value | −30K | $61.6672 | −$1.85M | 159.25K | −15.9% | SEC |
| Sep 3, 2025 | Sep 2, 2025 | Elkins David VEVP, Chief Financial Officer | SSaleCommon Stock, $0.10 par value | −56K | $47.33 | −$2.65M | 167.38K | −25.1% | SEC |
| Aug 5, 2025 | Aug 2, 2025 | Short Bartie WendyEVP, Corporate Affairs | SSaleCommon Stock, $0.10 par value | −378 | $44.23 | −$16.72K | 5.07K | −6.9% | SEC |
Top 5 13F holders, Q2 2026
View all: Top 5 13F holders, Q2 2026The largest institutional positions in BMY at the end of Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 180,384,994 | $10.39B | 0.15% | +8,702,106+5.1% | Added |
| Banque Cantonale Vaudoise | 136,299 | $7.85B | 1.09% | +23,197+20.5% | Added |
| VANGUARD CAPITAL MANAGEMENT LLC | 133,337,856 | $7.68B | 0.16% | +1,017,616+0.8% | Added |
| STATE STREET CORP | 102,408,940 | $5.9B | 0.17% | +3,844,026+3.9% | Added |
| JPMORGAN CHASE & CO | 71,713,442 | $4.2B | 0.25% | −20,761,752−22.5% | Reduced |